Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Hou

Showing results (671-680 of 755) with videos related to

Pageof 76
Sort By:
Human Mutation|July 5, 2017
Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardationStephanie N Oprescu, Xenia Chepa-Lotrea, Ryuichi Takase, et al.
Plos One|August 21, 2014
Distribution and determinants of non communicable diseases among elderly Uyghur ethnic group in Xinjiang, ChinaLei Feng, Ping Li, Xihua Wang, et al.
British Journal of Haematology|March 11, 2025
Effects of orelabrutinib, a BTK inhibitor, on antibody-mediated platelet destruction in primary immune thrombocytopeniaTian-Shu Yu, Shou-Qing Han, Ling-Jun Wang, et al.
Prostate Cancer and Prostatic Diseases|August 28, 2021
Initial Prostate Health Index (phi) and phi density predicts future risk of clinically significant prostate cancer in men with initial negative prostate biopsy: a 6-year follow-up studyAlex Qinyang Liu, Sebastiaan Remmers, Sui-Yan Lau, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Molecular mechanism of IF1- and IF2-driven translation initiation in bacteriaGabriel Soares Guerra, Hassan Zafar, Xueliang Ge, et al.
American Journal of Hematology|December 6, 2011
Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodiesQingshu Zeng, Lingyan Zhu, Lili Tao, et al.
Cellular and Molecular Life Sciences : CMLS|April 19, 2022
Platelets fine-tune effector responses of naïve CD4<sup>+</sup> T cells via platelet factor 4-regulated transforming growth factor β signalingYanan Min, Long Hao, Xinguang Liu, et al.
Chinese Medical Journal|August 22, 2025
Caffeic acid tablets plus high-dose dexamethasone versus placebo plus high-dose dexamethasone in patients with newly diagnosed immune thrombocytopenia: A multicenter, double-blind, randomized, controlled, phase 2 trialRuting Wang, Yang Liu, Ruixue Wang, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
Blood|December 16, 2018
Low-dose chidamide restores immune tolerance in ITP in mice and humansHong-Yu Zhao, Ya-Hui Ma, Da-Qi Li, et al.
Pageof 76

Showing results (671-680 of 755) with videos related to

Sort By:
Pageof 76
Human Mutation|July 5, 2017
Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardationStephanie N Oprescu, Xenia Chepa-Lotrea, Ryuichi Takase, et al.
Plos One|August 21, 2014
Distribution and determinants of non communicable diseases among elderly Uyghur ethnic group in Xinjiang, ChinaLei Feng, Ping Li, Xihua Wang, et al.
British Journal of Haematology|March 11, 2025
Effects of orelabrutinib, a BTK inhibitor, on antibody-mediated platelet destruction in primary immune thrombocytopeniaTian-Shu Yu, Shou-Qing Han, Ling-Jun Wang, et al.
Prostate Cancer and Prostatic Diseases|August 28, 2021
Initial Prostate Health Index (phi) and phi density predicts future risk of clinically significant prostate cancer in men with initial negative prostate biopsy: a 6-year follow-up studyAlex Qinyang Liu, Sebastiaan Remmers, Sui-Yan Lau, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Molecular mechanism of IF1- and IF2-driven translation initiation in bacteriaGabriel Soares Guerra, Hassan Zafar, Xueliang Ge, et al.
American Journal of Hematology|December 6, 2011
Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodiesQingshu Zeng, Lingyan Zhu, Lili Tao, et al.
Cellular and Molecular Life Sciences : CMLS|April 19, 2022
Platelets fine-tune effector responses of naïve CD4<sup>+</sup> T cells via platelet factor 4-regulated transforming growth factor β signalingYanan Min, Long Hao, Xinguang Liu, et al.
Chinese Medical Journal|August 22, 2025
Caffeic acid tablets plus high-dose dexamethasone versus placebo plus high-dose dexamethasone in patients with newly diagnosed immune thrombocytopenia: A multicenter, double-blind, randomized, controlled, phase 2 trialRuting Wang, Yang Liu, Ruixue Wang, et al.
American Journal of Hematology|June 4, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0Nichola Cooper, James Bussel, Waleed Ghanima, et al.
Blood|December 16, 2018
Low-dose chidamide restores immune tolerance in ITP in mice and humansHong-Yu Zhao, Ya-Hui Ma, Da-Qi Li, et al.
Pageof 76